BEST BUY CO INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BEST BUY CO INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $41.69B | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | $41.53B | Mar 18, 2026 |
| FY2026 | Feb 3, 2024 | $43.45B | Mar 18, 2026 |
| FY2025 | Jan 28, 2023 | $46.30B | Mar 19, 2025 |
| FY2024 | Jan 29, 2022 | $51.76B | Mar 15, 2024 |
| FY2023 | Jan 30, 2021 | $47.26B | Mar 17, 2023 |
| FY2022 | Feb 1, 2020 | $43.64B | Mar 18, 2022 |
| FY2020 | Feb 2, 2019 | $42.88B | Mar 19, 2021 |
| FY2020 | Feb 3, 2018 | $42.15B | Mar 23, 2020 |
| FY2019 | Jan 28, 2017 | $39.40B | Mar 28, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Feb 3, 2018 | $15.36B | Apr 2, 2018 |
| FY2018 | Oct 28, 2017 | $9.32B | Apr 2, 2018 |
| FY2018 | Jul 29, 2017 | $8.94B | Apr 2, 2018 |
| FY2018 | Apr 29, 2017 | $8.53B | Apr 2, 2018 |
| FY2018 | Jan 28, 2017 | $13.48B | Apr 2, 2018 |
| FY2018 | Oct 29, 2016 | $8.95B | Apr 2, 2018 |
| FY2018 | Jul 30, 2016 | $8.53B | Apr 2, 2018 |
| FY2018 | Apr 30, 2016 | $8.44B | Apr 2, 2018 |
| FY2017 | Jan 30, 2016 | $13.62B | Mar 24, 2017 |
| FY2017 | Oct 31, 2015 | $8.82B | Mar 24, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $9.37B | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | $9.39B | Mar 18, 2026 |
| FY2026 | Feb 3, 2024 | $9.60B | Mar 18, 2026 |
| FY2025 | Jan 28, 2023 | $9.91B | Mar 19, 2025 |
| FY2024 | Jan 29, 2022 | $11.64B | Mar 15, 2024 |
| FY2023 | Jan 30, 2021 | $10.57B | Mar 17, 2023 |
| FY2020 | Feb 1, 2020 | $3.24B | Mar 23, 2020 |
| FY2020 | Nov 2, 2019 | $2.36B | Mar 23, 2020 |
| FY2020 | Aug 3, 2019 | $2.28B | Mar 23, 2020 |
| FY2020 | May 4, 2019 | $2.17B | Mar 23, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.07B | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | $927.00M | Mar 18, 2026 |
| FY2026 | Feb 3, 2024 | $1.24B | Mar 18, 2026 |
| FY2025 | Jan 28, 2023 | $1.42B | Mar 19, 2025 |
| FY2024 | Jan 29, 2022 | $2.45B | Mar 15, 2024 |
| FY2023 | Jan 30, 2021 | $1.80B | Mar 17, 2023 |
| FY2020 | Feb 1, 2020 | $745.00M | Mar 23, 2020 |
| FY2020 | Nov 2, 2019 | $293.00M | Mar 23, 2020 |
| FY2020 | Aug 3, 2019 | $238.00M | Mar 23, 2020 |
| FY2020 | May 4, 2019 | $265.00M | Mar 23, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.39B | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | $1.26B | Mar 18, 2026 |
| FY2026 | Feb 3, 2024 | $1.57B | Mar 18, 2026 |
| FY2025 | Jan 28, 2023 | $1.80B | Mar 19, 2025 |
| FY2024 | Jan 29, 2022 | $3.04B | Mar 15, 2024 |
| FY2023 | Jan 30, 2021 | $2.39B | Mar 17, 2023 |
| FY2020 | Feb 1, 2020 | $967.00M | Mar 23, 2020 |
| FY2020 | Nov 2, 2019 | $395.00M | Mar 23, 2020 |
| FY2020 | Aug 3, 2019 | $313.00M | Mar 23, 2020 |
| FY2020 | May 4, 2019 | $334.00M | Mar 23, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $7.62B | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | $7.65B | Mar 18, 2026 |
| FY2026 | Feb 3, 2024 | $7.88B | Mar 18, 2026 |
| FY2025 | Jan 28, 2023 | $7.97B | Mar 19, 2025 |
| FY2024 | Jan 29, 2022 | $8.64B | Mar 15, 2024 |
| FY2023 | Jan 30, 2021 | $7.93B | Mar 17, 2023 |
| FY2022 | Feb 1, 2020 | $8.00B | Mar 18, 2022 |
| FY2020 | Feb 2, 2019 | $8.02B | Mar 19, 2021 |
| FY2020 | Feb 3, 2018 | $8.02B | Mar 23, 2020 |
| FY2019 | Jan 28, 2017 | $7.55B | Mar 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.96B | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | $2.10B | Mar 18, 2026 |
| FY2026 | Feb 3, 2024 | $1.47B | Mar 18, 2026 |
| FY2025 | Jan 28, 2023 | $1.82B | Mar 19, 2025 |
| FY2024 | Jan 29, 2022 | $3.25B | Mar 15, 2024 |
| FY2023 | Jan 30, 2021 | $4.93B | Mar 17, 2023 |
| FY2022 | Feb 1, 2020 | $2.57B | Mar 18, 2022 |
| FY2020 | Feb 2, 2019 | $2.41B | Mar 19, 2021 |
| FY2020 | Feb 3, 2018 | $2.14B | Mar 23, 2020 |
| FY2019 | Jan 28, 2017 | $2.56B | Mar 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $704.00M | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | $706.00M | Mar 18, 2026 |
| FY2026 | Feb 3, 2024 | $795.00M | Mar 18, 2026 |
| FY2025 | Jan 28, 2023 | $930.00M | Mar 19, 2025 |
| FY2024 | Jan 29, 2022 | $737.00M | Mar 15, 2024 |
| FY2023 | Jan 30, 2021 | $713.00M | Mar 17, 2023 |
| FY2022 | Feb 1, 2020 | $743.00M | Mar 18, 2022 |
| FY2020 | Feb 2, 2019 | $819.00M | Mar 19, 2021 |
| FY2020 | Feb 3, 2018 | $688.00M | Mar 23, 2020 |
| FY2019 | Jan 28, 2017 | $580.00M | Mar 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $14.67B | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | $14.78B | Mar 18, 2026 |
| FY2025 | Feb 3, 2024 | $14.97B | Mar 19, 2025 |
| FY2025 | Jan 28, 2023 | $15.80B | Mar 19, 2025 |
| FY2024 | Jan 29, 2022 | $17.50B | Mar 15, 2024 |
| FY2023 | Jan 30, 2021 | $19.07B | Mar 17, 2023 |
| FY2022 | Feb 1, 2020 | $15.59B | Mar 18, 2022 |
| FY2020 | Feb 2, 2019 | $12.90B | Mar 19, 2021 |
| FY2020 | Feb 3, 2018 | $13.05B | Mar 23, 2020 |
| FY2019 | Jan 28, 2017 | $13.86B | Mar 28, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $2.96B | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | $2.81B | Mar 18, 2026 |
| FY2025 | Feb 3, 2024 | $3.05B | Mar 19, 2025 |
| FY2024 | Jan 28, 2023 | $2.80B | Mar 15, 2024 |
| FY2023 | Jan 29, 2022 | $3.02B | Mar 17, 2023 |
| FY2022 | Jan 30, 2021 | $4.59B | Mar 18, 2022 |
| FY2020 | Feb 1, 2020 | $3.48B | Mar 19, 2021 |
| FY2020 | Feb 2, 2019 | $3.31B | Mar 23, 2020 |
| FY2016 | Jan 30, 2016 | $4.38B | Mar 23, 2016 |
| FY2016 | Jan 31, 2015 | $5.00B | Mar 23, 2016 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $790.00M | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | $908.00M | Mar 18, 2026 |
| FY2025 | Feb 3, 2024 | $1.38B | Mar 19, 2025 |
| FY2024 | Jan 28, 2023 | $1.38B | Mar 15, 2024 |
| FY2023 | Jan 29, 2022 | $1.38B | Mar 17, 2023 |
| FY2022 | Jan 30, 2021 | $986.00M | Mar 18, 2022 |
| FY2020 | Feb 1, 2020 | $984.00M | Mar 19, 2021 |
| FY2020 | Feb 2, 2019 | $915.00M | Mar 23, 2020 |
| FY2020 | Oct 1, 2018 | $490.00M | Mar 23, 2020 |
| FY2019 | Feb 3, 2018 | $425.00M | Mar 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $2.61B | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | $2.49B | Mar 18, 2026 |
| FY2025 | Feb 3, 2024 | $2.68B | Mar 19, 2025 |
| FY2024 | Jan 28, 2023 | $2.43B | Mar 15, 2024 |
| FY2023 | Jan 29, 2022 | $2.67B | Mar 17, 2023 |
| FY2022 | Jan 30, 2021 | $4.23B | Mar 18, 2022 |
| FY2020 | Feb 1, 2020 | $3.16B | Mar 19, 2021 |
| FY2020 | Feb 2, 2019 | $2.99B | Mar 23, 2020 |
| FY2019 | Feb 4, 2018 | $3.34B | Mar 28, 2019 |
| FY2019 | Feb 3, 2018 | $3.27B | Mar 28, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.74B | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | $1.58B | Mar 18, 2026 |
| FY2026 | Feb 3, 2024 | $1.45B | Mar 18, 2026 |
| FY2025 | Jan 28, 2023 | $1.87B | Mar 19, 2025 |
| FY2024 | Jan 29, 2022 | $2.94B | Mar 15, 2024 |
| FY2023 | Jan 30, 2021 | $5.49B | Mar 17, 2023 |
| FY2020 | Feb 1, 2020 | $2.23B | Mar 19, 2021 |
| FY2020 | Feb 2, 2019 | $1.98B | Mar 23, 2020 |
| FY2019 | Feb 3, 2018 | $1.10B | Mar 28, 2019 |
| FY2019 | Jan 28, 2017 | $2.24B | Mar 28, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 1, 2025 | $1.15B | Mar 19, 2025 |
| FY2025 | Feb 3, 2024 | $1.17B | Mar 19, 2025 |
| FY2024 | Jan 28, 2023 | $1.18B | Mar 15, 2024 |
| FY2023 | Jan 29, 2022 | $1.23B | Mar 17, 2023 |
| FY2022 | Jan 30, 2021 | $1.27B | Mar 18, 2022 |
| FY2020 | Feb 1, 2020 | $1.27B | Mar 19, 2021 |
| FY2020 | Feb 2, 2019 | $1.39B | Mar 23, 2020 |
| FY2017 | Jan 28, 2017 | $1.16B | Mar 24, 2017 |
| FY2017 | Jan 30, 2016 | $1.53B | Mar 24, 2017 |
| FY2016 | Jan 31, 2015 | $1.50B | Mar 23, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 5 | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | 4 | Mar 18, 2026 |
| FY2026 | Feb 3, 2024 | 5 | Mar 18, 2026 |
| FY2025 | Jan 28, 2023 | 6 | Mar 19, 2025 |
| FY2024 | Jan 29, 2022 | 9 | Mar 15, 2024 |
| FY2023 | Jan 30, 2021 | 6 | Mar 17, 2023 |
| FY2020 | Feb 1, 2020 | 2 | Mar 23, 2020 |
| FY2020 | Nov 2, 2019 | 1 | Mar 23, 2020 |
| FY2020 | Aug 3, 2019 | 0 | Mar 23, 2020 |
| FY2020 | May 4, 2019 | 0 | Mar 23, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 5 | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | 4 | Mar 18, 2026 |
| FY2026 | Feb 3, 2024 | 5 | Mar 18, 2026 |
| FY2025 | Jan 28, 2023 | 6 | Mar 19, 2025 |
| FY2024 | Jan 29, 2022 | 9 | Mar 15, 2024 |
| FY2023 | Jan 30, 2021 | 6 | Mar 17, 2023 |
| FY2020 | Feb 1, 2020 | 2 | Mar 23, 2020 |
| FY2020 | Nov 2, 2019 | 1 | Mar 23, 2020 |
| FY2020 | Aug 3, 2019 | 0 | Mar 23, 2020 |
| FY2020 | May 4, 2019 | 0 | Mar 23, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 209.10M | Mar 18, 2026 |
| FY2026 | Feb 1, 2025 | 211.40M | Mar 18, 2026 |
| FY2025 | Feb 3, 2024 | 215.40M | Mar 19, 2025 |
| FY2024 | Jan 28, 2023 | 218.10M | Mar 15, 2024 |
| FY2023 | Jan 29, 2022 | 227.40M | Mar 17, 2023 |
| FY2022 | Jan 30, 2021 | 256.90M | Mar 18, 2022 |
| FY2020 | Feb 1, 2020 | 256.00M | Mar 19, 2021 |
| FY2020 | Feb 2, 2019 | 265.70M | Mar 23, 2020 |
| FY2019 | Feb 3, 2018 | 282.99M | Mar 28, 2019 |
| FY2018 | Jan 28, 2017 | 311.11M | Apr 2, 2018 |